Skandinaviska Enskilda Banken (SEB)
RMD icon

Skandinaviska Enskilda Banken (SEB)’s ResMed RMD Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-141,153
Closed -$34M – 592
2025
Q4 		$34M Buy
141,153
+55,139
+64% +$14.1M 0.14% 123
2025
Q3 		$23.5M Sell
86,014
-49,690
-37% -$13.6M 0.09% 172
2025
Q2 		$35M Sell
135,704
-70,399
-34% -$16.8M 0.15% 118
2025
Q1 		$46.1M Sell
206,103
-18,300
-8% -$4.27M 0.23% 84
2024
Q4 		$51.5M Buy
224,403
+69,782
+45% +$16.8M 0.23% 72
2024
Q3 		$37.7M Buy
154,621
+122,888
+387% +$27.5M 0.17% 104
2024
Q2 		$6.07M Buy
31,733
+904
+3% +$183K 0.03% 347
2024
Q1 		$6.11M Buy
30,829
+635
+2% +$116K 0.03% 367
2023
Q4 		$5.19M Buy
30,194
+848
+3% +$130K 0.03% 377
2023
Q3 		$4.34M Buy
29,346
+149
+0.5% +$26.9K 0.03% 381
2023
Q2 		$6.38M Buy
29,197
+3,064
+12% +$683K 0.04% 345
2023
Q1 		$5.72M Buy
26,133
+45
+0.2% +$9.76K 0.04% 353
2022
Q4 		$5.43M Sell
26,088
-54
-0.2% -$11.9K 0.04% 344
2022
Q3 		$5.71M Sell
26,142
-1,422
-5% -$324K 0.04% 334
2022
Q2 		$5.78M Sell
27,564
-826
-3% -$176K 0.04% 342
2022
Q1 		$6.88M Sell
28,390
-9,211
-24% -$2.23M 0.04% 338
2021
Q4 		$9.85M Sell
37,601
-53,923
-59% -$14M 0.05% 296
2021
Q3 		$24.1M Buy
91,524
+6,889
+8% +$1.88M 0.13% 160
2021
Q2 		$20.9M Sell
84,635
-10,967
-11% -$2.31M 0.13% 165
2021
Q1 		$18.5M Sell
95,602
-103,765
-52% -$20.8M 0.12% 167
2020
Q4 		$42.4M Buy
199,367
+121,205
+155% +$24.2M 0.29% 79
2020
Q3 		$13.4M Buy
78,162
+24,021
+44% +$4.44M 0.1% 191
2020
Q2 		$10.4M Buy
54,141
+24,092
+80% +$3.94M 0.08% 224
2020
Q1 		$4.43M Sell
30,049
-3,644
-11% -$580K 0.04% 290
2019
Q4 		$5.22M Sell
33,693
-87,881
-72% -$12.7M 0.04% 330
2019
Q3 		$16.4M Buy
121,574
+1,996
+2% +$262K 0.14% 145
2019
Q2 		$14.6M Buy
119,578
+2,434
+2% +$270K 0.13% 160
2019
Q1 		$12.2M Sell
117,144
-74,770
-39% -$7.72M 0.11% 164
2018
Q4 		$21.9M Buy
191,914
+171,367
+834% +$18.4M 0.2% 106
2018
Q3 		$2.37M Sell
20,547
-200
-1% -$21.9K 0.02% 440
2018
Q2 		$2.15M Buy
20,747
+1,293
+7% +$131K 0.02% 423
2018
Q1 		$1.92M Sell
19,454
-3,817
-16% -$361K 0.02% 414
2017
Q4 		$1.97M Buy
23,271
+891
+4% +$73.6K 0.02% 449
2017
Q3 		$1.72M Buy
22,380
+3,700
+20% +$283K 0.02% 488
2017
Q2 		$1.46M Sell
18,680
-976
-5% -$69.8K 0.01% 532
2017
Q1 		$1.42M Buy
19,656
+1,200
+7% +$82.9K 0.01% 521
2016
Q4 		$1.15M Sell
18,456
-644
-3% -$39.4K 0.01% 518
2016
Q3 		$1.24M Buy
19,100
+3,500
+22% +$233K 0.01% 562
2016
Q2 		$986K Hold
15,600
– – 0.01% 580
2016
Q1 		$902K Sell
15,600
-600
-4% -$34K 0.01% 598
2015
Q4 		$870K Buy
+16,200
New +$913K 0.01% 529

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s RMD Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of ResMed (RMD) in Q1 2026, closing a stake of 141,153 shares — an estimated $34M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in RMD in Q4 2015 and held it in 41 quarters. The position peaked at $51.5M in Q4 2024. 941 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 141,153 ResMed shares in Q1 2026, an estimated $34M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in ResMed in Q4 2015 and held it in 41 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s ResMed position peaked at $51.5M in Q4 2024.
  • 941 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.